JMP Securities Maintains Market Outperform on Sana Biotechnology, Raises Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Reni Benjamin maintains a Market Outperform rating on Sana Biotechnology (NASDAQ:SANA) and raises the price target from $8 to $15.
March 01, 2024 | 4:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JMP Securities analyst Reni Benjamin maintains a Market Outperform rating on Sana Biotechnology and raises the price target from $8 to $15.
The increase in price target by JMP Securities from $8 to $15 reflects a positive outlook on Sana Biotechnology's future performance. This endorsement from a reputable analyst is likely to instill confidence in investors, potentially driving up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100